This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Sk Biopharmaceuticals., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Soo Yeon Jung
Introduction
Soo Yeon Jung is an inventor based in South Korea, recognized for his contributions to the field of medicinal chemistry. His work primarily focuses on developing compounds that exhibit significant biological activity, particularly in the realm of protein kinase inhibition.
Latest Patents
Soo Yeon Jung currently holds a patent titled "Heterocyclic Compound As A Protein Kinase Inhibitor." This invention provides a compound that demonstrates protein kinase inhibition activity, along with its stereoisomers or pharmaceutically acceptable salts. The compounds described in this patent are effective in preventing or treating various diseases associated with protein kinases, including cancer, autoimmune diseases, neurological disorders, and metabolic diseases.
Career Highlights
Throughout his career, Soo Yeon Jung has made notable strides in the development of therapeutic agents. His research has contributed to a deeper understanding of protein kinases and their role in disease mechanisms. Despite having 1 patents to his name, his work remains influential in the scientific community.
Collaborations
Soo Yeon Jung has collaborated with Mi Kyung Ji, enhancing the research and development of innovative compounds. Their partnership has focused on exploring the therapeutic potential of various heterocyclic compounds.
Conclusion
Soo Yeon Jung's work in the field of protein kinase inhibitors showcases his commitment to advancing medical science. His innovative approach to developing therapeutic compounds holds promise for future treatments of serious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile